Recently there has been a lot of news related to the safety of the bleeding disorders community. HFA & NHF are working together to address the issues important to patients.
NHF and HFA have received additional information from Bayer regarding the Kogenate FS recall.
Genentech Patient Foundation responded to questions from NHF and HFA.
NHF and HFA have sent a letter to Genentech and Medvantx asking for further information on how the error occured.
Ancillary supplies shipped by a specialty pharmacy, Medvantx, to a specific group of patients receiving Hemlibra through the Genentech Patient Foundation contained incorrect length injection needles.
MyBDC is a new way to ensure the community’s voice is heard.
NHF's gala raised more than $370,000 to support programs and services for people with bleeding disorders.
NHF and HFA asked questions focusing on short- and long-term medical consequences for affected patients.
Bayer has responded to NHF's and HFA's queries regarding the recall.
Meet the team who are dedicating their 26-mile run to NHF.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car